Clinical Trial Update: Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis

View source ↗

Summary

The clinical trial investigating the contribution of hepatic and intestinal lipoproteins to human atherosclerosis has been withdrawn. Sponsored by Piedmont Heal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Snippet

Sponsor: Piedmont Healthcare | Conditions: Heart Disease | Status: WITHDRAWN